Integra LifeSciencesvsJohnson & Johnson

IART and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

IART

Integra LifeSciences Holdings Corporation

$13.29

Value $1.0B

-1.81%
IART's page

Integra LifeSciences (IART) has a market value of $1.0B and Johnson & Johnson (JNJ) $654B. Over the last year, with dividends, IART moved +19.4% and JNJ +37.0%. The P/E is 79.6 for IART and 40.6 for JNJ. Dividend yield: IART none, JNJ 1.95%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    IART$1.0B

    JNJ$654B

    JNJ is 631 times IART

  • Revenue, 12 months

    IART$1.7B

    JNJ$99.3B

    JNJ is 60 times IART

  • Net income, 12 months

    IART$13M

    JNJ$16.1B

    JNJ is 1,237 times IART

  • Operating margin

    IART4.4%

    JNJ–

  • ROIC

    IART2.7%

    JNJ12.4%

    9.7 points apart

  • P/E

    IART79.6

    JNJ40.6

    IART is 2.0 times JNJ

  • Dividend yield

    IART0.0%

    JNJ2.0%

    2.0 points apart

  • 5-year return

    IART-80.7%

    JNJ+91.5%

    172.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

IART-80.7%

JNJ+91.5%

10020020222023202420252026
Returns by period
PeriodIARTWith dividendsJNJWith dividends
1 year since November 19, 2025+19.4%Price +19.4%+37.0%Price +34.0%
3 years since November 20, 2023-65.6%-29.9% a yearPrice -65.6%+95.6%+25.1% a yearPrice +81.0%
5 years since November 19, 2021-80.7%-28.0% a yearPrice -80.7%+91.5%+13.9% a yearPrice +66.6%
10 years since November 21, 2016-67.7%-10.7% a yearPrice -67.7%+207.5%+11.9% a yearPrice +136.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

IARTIntegra LifeSciencesJNJJohnson & Johnson

Valuation

IARTJNJ
Valuation
Price$13.29$271.37
Market value$1.0B$654B
Enterprise value (EV)–$681B
P/E79.640.6
P/E, 5-year median33.821.9
P/B1.08.0
EV/EBIT–38.4
Free cash flow yield8.3%3.2%

Results and growth

IARTJNJ
Results and growth
Revenue, 12 months$1.7B$99.3B
Net income, 12 months$13M$16.1B
Free cash flow, 12 months$86M$20.6B
Earnings per share, 12 months$0.17$6.59
Revenue growth, year on year1.5%6.1%
Revenue growth a year, past+3.6%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

IARTJNJ
Margins and returns on capital
Gross margin52.4%67.6%
Operating margin4.4%–
Net margin0.8%16.2%
ROIC2.7%12.4%
ROE1.2%19.7%

Balance sheet

IARTJNJ
Balance sheet
Cash$312M$17.2B
Total debt–$44.7B
Net debt / EBITDA–1.1
Interest cover0.8×18.0×

Dividends and buybacks

IARTJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield0.0%0.9%
Shareholder yield0.0%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: IART or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Integra LifeSciences or Johnson & Johnson?

By market value, Johnson & Johnson ($654B) is about 631.1 times Integra LifeSciences ($1.0B), at today's prices.

How did IART and JNJ stock do over the last 10 years?

Since November 21, 2016, IART's price moved -67.7% and JNJ's +136.0%. With dividends: IART -67.7% (-10.7% a year), JNJ +207.5% (+11.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, IART or JNJ?

The dividend yield at today's price is none for Integra LifeSciences and 1.95% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of IART and JNJ?

At today's price, the P/E is 79.6 for IART and 40.6 for JNJ. The median of the last five years was 33.8 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Integra LifeSciences or Johnson & Johnson?

Over the last twelve months, the net margin was 0.8% for Integra LifeSciences and 16.2% for Johnson & Johnson, and the operating margin 4.4% and –. Revenue was $1.7B and $99.3B.

Which is the better investment, Integra LifeSciences or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.